Apimeds Pharmaceuticals US, Inc. (APUS)

APUS Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	28	-	-	-	-
Enterprise Value	20	-	-	-	-
Debt / Equity Ratio	0.05	-0.50	8.38	-0.96	-1.68
Quick Ratio	10.80	0.00	3.33	0.02	16.09
Current Ratio	12.79	0.01	3.42	0.02	16.16
Return on Assets (ROA)	-42.42%	-366.30%	-218.17%	-448.25%	-
Return on Capital (ROIC)	-45.40%	-	-348.55%	-611.12%	-
Buyback Yield / Dilution	-28.67%	-71.89%	-19.55%	-	-

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q